CN102153519B - 一类喹唑啉衍生物的制备方法 - Google Patents
一类喹唑啉衍生物的制备方法 Download PDFInfo
- Publication number
- CN102153519B CN102153519B CN201110040444A CN201110040444A CN102153519B CN 102153519 B CN102153519 B CN 102153519B CN 201110040444 A CN201110040444 A CN 201110040444A CN 201110040444 A CN201110040444 A CN 201110040444A CN 102153519 B CN102153519 B CN 102153519B
- Authority
- CN
- China
- Prior art keywords
- preparation
- quinazoline derivant
- compound
- carbon
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- WFUBWLXSYCFZEH-UHFFFAOYSA-N COc(cc(c1c2)N=CNC1=O)c2OCCCN1CCOCC1 Chemical compound COc(cc(c1c2)N=CNC1=O)c2OCCCN1CCOCC1 WFUBWLXSYCFZEH-UHFFFAOYSA-N 0.000 description 2
- XGALLCVXEZPNRQ-UHFFFAOYSA-N COc1cc2ncnc(Nc(cc3Cl)ccc3F)c2cc1OCCCN1CCOCC1 Chemical compound COc1cc2ncnc(Nc(cc3Cl)ccc3F)c2cc1OCCCN1CCOCC1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 2
- YSEMCVGMNUUNRK-UHFFFAOYSA-N Nc(cc1)cc(Cl)c1F Chemical compound Nc(cc1)cc(Cl)c1F YSEMCVGMNUUNRK-UHFFFAOYSA-N 0.000 description 2
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110040444A CN102153519B (zh) | 2011-02-18 | 2011-02-18 | 一类喹唑啉衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110040444A CN102153519B (zh) | 2011-02-18 | 2011-02-18 | 一类喹唑啉衍生物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102153519A CN102153519A (zh) | 2011-08-17 |
CN102153519B true CN102153519B (zh) | 2012-10-24 |
Family
ID=44435235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110040444A Expired - Fee Related CN102153519B (zh) | 2011-02-18 | 2011-02-18 | 一类喹唑啉衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102153519B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102432553B (zh) * | 2011-10-28 | 2014-12-10 | 云南维和控股有限公司 | 喹唑啉衍生物的制备方法及其中间体 |
CN102584720B (zh) * | 2012-02-02 | 2014-12-17 | 瑞阳制药有限公司 | 高纯度吉非替尼的制备工艺 |
CN103910690A (zh) * | 2013-01-06 | 2014-07-09 | 上海科胜药物研发有限公司 | 一种吉非替尼新晶型及其制备方法 |
CN103275020A (zh) * | 2013-05-06 | 2013-09-04 | 苏州立新制药有限公司 | 厄洛替尼的制备方法 |
CN103288808B (zh) * | 2013-05-16 | 2015-11-11 | 苏州明锐医药科技有限公司 | 一种阿法替尼的制备方法 |
CN103242244B (zh) * | 2013-05-16 | 2015-03-25 | 苏州明锐医药科技有限公司 | 一种卡奈替尼的制备方法 |
CN103242245B (zh) * | 2013-05-22 | 2015-05-20 | 苏州明锐医药科技有限公司 | 坦度替尼的制备方法 |
CN103275072B (zh) * | 2013-05-22 | 2016-01-20 | 苏州明锐医药科技有限公司 | 塞卡替尼的制备方法 |
CN104230823A (zh) * | 2013-06-08 | 2014-12-24 | 重庆圣华曦药业股份有限公司 | 一种吉非替尼的制备方法 |
CN103435598B (zh) * | 2013-07-25 | 2015-08-05 | 苏州明锐医药科技有限公司 | 巴拉塞替的制备方法 |
CN111499583B (zh) * | 2020-05-22 | 2022-02-15 | 沈阳工业大学 | 喹唑啉衍生物及其作为抗肿瘤药物的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211240A (zh) * | 1996-02-14 | 1999-03-17 | 曾尼卡有限公司 | 作为抗肿瘤剂的喹唑啉衍生物 |
CN101463012A (zh) * | 2007-12-18 | 2009-06-24 | 上海百灵医药科技有限公司 | 一种吉非替尼的制备方法 |
CN101570516A (zh) * | 2009-04-14 | 2009-11-04 | 重庆威尔德·浩瑞医药化工有限公司 | 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉的方法 |
WO2010076810A2 (en) * | 2008-12-30 | 2010-07-08 | Ind-Swift Laboratories Limited | A process for the preparation of gefitinib |
-
2011
- 2011-02-18 CN CN201110040444A patent/CN102153519B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1211240A (zh) * | 1996-02-14 | 1999-03-17 | 曾尼卡有限公司 | 作为抗肿瘤剂的喹唑啉衍生物 |
CN101463012A (zh) * | 2007-12-18 | 2009-06-24 | 上海百灵医药科技有限公司 | 一种吉非替尼的制备方法 |
WO2010076810A2 (en) * | 2008-12-30 | 2010-07-08 | Ind-Swift Laboratories Limited | A process for the preparation of gefitinib |
CN101570516A (zh) * | 2009-04-14 | 2009-11-04 | 重庆威尔德·浩瑞医药化工有限公司 | 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102153519A (zh) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102153519B (zh) | 一类喹唑啉衍生物的制备方法 | |
TWI828649B (zh) | 聯芳基衍生物、其製備方法和在藥學上的應用 | |
CN102321032A (zh) | 一类喹唑啉衍生物的制备方法 | |
CA2583907C (en) | Heteroaryl-substituted alkyne compounds and method of use | |
JP5789259B2 (ja) | 含窒素芳香族複素環誘導体 | |
CN103965120A (zh) | 喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用 | |
RU2711500C2 (ru) | Композиции и способы, которые можно использовать для лечения пролиферативных заболеваний | |
TWI739825B (zh) | 一種製備酪胺酸激酶抑制劑及其衍生物的方法 | |
CN103965114B (zh) | 氘代的苯基氨基嘧啶化合物以及包含该化合物的药物组合物 | |
JP2013516420A (ja) | 置換されたピロロ−アミノピリミジン化合物 | |
CA2561895A1 (en) | Polycyclic pyrimidines as potassium ion channel modulators | |
JP2009023986A (ja) | 抗癌剤としてのビアリール誘導体 | |
CN110511158A (zh) | 制备喹啉衍生物的方法 | |
CN101497601B (zh) | 伊马替尼的合成方法 | |
CN110372598A (zh) | 一种合成氘代酰胺及氘代磺酰胺的新方法 | |
CN110092787A (zh) | 一种化合物或其药用盐或组合物的制备及应用 | |
CN106478605A (zh) | 嘧啶类化合物、其制备方法和医药用途 | |
AU2015276699A1 (en) | Pyridino[1,2-a]pyrimidone analogue used as PI3K inhibitor | |
CN104844566A (zh) | 一种新型结构的激酶抑制剂 | |
CN105524045A (zh) | 四环类间变性淋巴瘤激酶抑制剂 | |
CN105198821A (zh) | 洛昔替尼的制备方法 | |
CN105884695A (zh) | 杂环衍生物类酪氨酸激酶抑制剂 | |
CN103613619B (zh) | N-4-苯磺酰胺基-N’-1-脱氧-β-D-吡喃葡萄糖醛酸基-硫脲化合物的制备方法及医药用途 | |
CN105037236A (zh) | 瑞博西尼中间体及其制备方法 | |
CN103113355A (zh) | 一种Bcr/Abl酪氨酸激酶抑制剂及其制备方法和在治疗慢性粒细胞白血病中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI LONGWOOD PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI CHANGLIN CHEMICAL TECHNOLOGY CO.,LTD. Effective date: 20140402 Owner name: SHANGHAI CHANGLIN CHEMICAL TECHNOLOGY CO.,LTD. Effective date: 20140402 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200331 PUTUO, SHANGHAI TO: 201203 PUDONG NEW AREA, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140402 Address after: 201203 Shanghai Guo Shou Jing Road, Zhangjiang High Tech Park of Pudong New Area No. 199 Chinese Medicine Innovation Park Room 315 Patentee after: Shanghai Longwood Pharmaceutical Co., Ltd. Patentee after: Shanghai Changlin Chemical Technology Co.,Ltd. Address before: 200331, room 4, building 1570, Lane 303, Gulang Road, Shanghai, Putuo District Patentee before: Shanghai Changlin Chemical Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121024 Termination date: 20160218 |